Study of E7386 in Participants With Selected Advanced Neoplasms
Study of E7386 in Participants With Selected Advanced Neoplasms
Active, not recruiting · NCT03264664 · Registry updated 2026-06-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of E7386 in Participants With Selected Advanced Neoplasms | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Active, not recruiting | Phase 1 | 2026-06-08 | NCT03264664 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eisai Inc. | 40 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| California Liver Research Institute | Pasadena | United States | 10 |
| Imperial College Healthcare NHS Trust | London | United Kingdom | 11 |
| Mayo Clinic Comprehensive Cancer | Jacksonville | United States | 1 |
| Mayo Clinic Comprehensive Caner | Phoenix | United States | 1 |
| Mayo Clinic Comprehensive Caner | Rochester | United States | 1 |
| Royal Marsden Hospital NHS Foundation Trust | Sutton | United Kingdom | 4 |
| The Beatson West of Scotland Cancer Centre | Glasgow | United Kingdom | 1 |
| The Christie NHS Foundation Trust | Manchester | United Kingdom | 5 |
| Usc Norris Comprehensive Cancer Center | Los Angeles | United States | 67 |
| UT Southwestern Medical Center | Dallas | United States | 210 |